Nanogels in the Treatment of Oral Thrush

The oral mucosa is impacted by the opportunistic infection known as oral candidiasis, sometimes referred to as candidosis. It is known as oral thrush or candidiasis. Any kind of Candida can cause this mycosis, or fungal infection, and while more species are emerging and getting isolated such as Candida parapsilosis, Candida albinos, Candida glabrata, Candida tropicalis, and Candida krusei most infections are still caused by Candida albicans. Treatment has benefited greatly from the systemic azoles, ketoconazole, fluconazole, and itraconazole. Nanogels are widely recognized for being incredibly adaptable drug delivery systems that significantly improve a variety of therapies and diagnostic procedures for many human ailments. These hydrophilic cross-linked polymers are three dimensional and may absorb a lot of biological fluids or water. Nanogels have become the next-generation drug delivery systems due to the increasing demand for improving existing medicines. They are regarded as a cutting-edge medication delivery system that exposes the drawbacks of conventional techniques. Nanotechnology is essential for creating novel and more potent medications, especially considering the current need to improve ongoing treatments and diagnostic tests. The ability of nanogel formulations to change a drug’s profile, peptide, genotype, oligosaccharide, protein, and immunogenic substance, as well as its ability to cross biological barriers, pharmacokinetics, and biodistribution, has been heralded as a promising target for drug delivery systems. This may enhance patient compliance, safety, and effectiveness. This article reviews several approaches of nanogel preparation. Methods for characterizing nanogels are discussed.